PureTech Health (PRTC) EPS (Basic) (2024 - 2025)

PureTech Health (PRTC) reported EPS (Basic) of -$9.18 for Q2 2025, down 5490.68% on a QoQ basis from -$0.16 in Q4 2024.

PureTech Health (PRTC) has 2 years of EPS (Basic) data on file, last reported at -$9.18 in Q2 2025.

  • Quarterly EPS (Basic) changed N/A year-over-year to -$9.18 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$9.34 (down 5590.68% YoY) and the FY2025 annual result came in at -$0.46, down 319.05% from the prior year.
  • EPS (Basic) fell to -$9.18 in Q2 2025 per PRTC's latest filing, from -$0.16 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.16 in Q4 2024 and bottomed at -$9.18 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 3.06
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 0.00
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 0.00
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 4.06
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 6.99
8 Evaxion A 65.44 Bn 65.42 Bn - 0.00
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1.55
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -9.18
Dec 31, 2024 -0.16